We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $25.2M invested in Aptevo Therapeutics in 2018 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less capital invested

Capital invested by funds: $29.6M → $25.2M (-$4.36M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SC
1
Sessa Capital
New York
$6.28M
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$3.99M
Renaissance Technologies
3
Renaissance Technologies
New York
$2.45M
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.42M
BlackRock
5
BlackRock
New York
$1.14M
D.E. Shaw & Co
6
D.E. Shaw & Co
New York
$927K
JP Morgan Chase
7
JP Morgan Chase
New York
$832K
Victory Capital Management
8
Victory Capital Management
Texas
$703K
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$671K
CL
10
CSS LLC
Illinois
$647K
AIM
11
Alambic Investment Management
California
$646K
PWAM
12
Park West Asset Management
California
$604K
OAM
13
Oxford Asset Management
United Kingdom
$460K
SIM
14
Spark Investment Management
New York
$423K
Millennium Management
15
Millennium Management
New York
$317K
Geode Capital Management
16
Geode Capital Management
Massachusetts
$314K
BCM
17
Bridgeway Capital Management
Texas
$307K
Macquarie Group
18
Macquarie Group
Australia
$267K
QI
19
QS Investors
New York
$207K
Northern Trust
20
Northern Trust
Illinois
$190K
Morgan Stanley
21
Morgan Stanley
New York
$154K
UBS Group
22
UBS Group
Switzerland
$149K
ACA
23
Atlas Capital Advisors
Wyoming
$143K
Citadel Advisors
24
Citadel Advisors
Florida
$130K
ARTA
25
A.R.T. Advisors
New York
$90K